Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

Scientific Statement Reviews Current Antithrombotic Options in PAD

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

August 26, 2024

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

News Daily News

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

July 02, 2024

DOAC Don’ts New Review Clarifies When Not to Use Direct Oral Anticoagulants

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

January 17, 2024

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

July 11, 2023

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

News Daily News

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

March 29, 2023

Social Factors Contribute to Race Differences in Premature CVD: CARDIA

News Daily News

Social Factors Contribute to Race Differences in Premature CVD: CARDIA

Yael L. Maxwell

May 30, 2022

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Michael O'Riordan

February 10, 2022

Rivaroxaban-Aspirin Combo Works in ASCVD Across BMI Groups

News Daily News

Rivaroxaban-Aspirin Combo Works in ASCVD Across BMI Groups

February 01, 2021

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

News Daily News

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

Michael O'Riordan

November 26, 2020

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

June 25, 2020

COVID-19 in NYC: CV Risk Factors and Bleak Outcomes in the Critically Ill

News Daily News

COVID-19 in NYC: CV Risk Factors and Bleak Outcomes in the Critically Ill

Michael O'Riordan

May 19, 2020

COMPASS Antithrombotic Approach Works Well in Prior-PCI Patients

News Daily News

COMPASS Antithrombotic Approach Works Well in Prior-PCI Patients

March 27, 2020

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

Bleeding on Low-Dose Antithrombotic Therapy a ‘Red Flag’ for New Cancers

News Daily News

Bleeding on Low-Dose Antithrombotic Therapy a ‘Red Flag’ for New Cancers

Yael L. Maxwell

September 20, 2019

Which ASCVD Patients Will Benefit Most From Rivaroxaban Plus Aspirin? Some Clues

News Daily News

Which ASCVD Patients Will Benefit Most From Rivaroxaban Plus Aspirin? Some Clues

June 26, 2019

NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin

News Daily News

NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin

May 16, 2018

TCTMD’s Top 10 Most Popular Stories for January 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for January 2018

January 31, 2018

The Biggest News of 2017: TCTMD’s Top 10

News Daily News

The Biggest News of 2017: TCTMD’s Top 10

January 01, 2018

Aspirin Use by Elderly Patients After Vascular Events Linked to More Bleeding, Especially GI Bleeds

News Daily News

Aspirin Use by Elderly Patients After Vascular Events Linked to More Bleeding, Especially GI Bleeds

Michael O'Riordan

June 14, 2017

Rivaroxaban’s “Overwhelming” Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS

News Daily News

Rivaroxaban’s ‘Overwhelming’ Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS

February 08, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.